Trial intelligence / Profile preview

Canephron N vs Fosfomycin in Acute Lower uUTI

NCT02639520Phase 3Completed

Sponsor
Bionorica
Start
Dec 2015
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Canephron in acute lower urinary tract infection, sponsored by Bionorica. Started Dec 2015; status: completed.

02

Drugs

Canephron
03

Conditions

acute lower urinary tract infection

Beyond the preview

Go deeper on NCT02639520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02639520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call